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ABSTRACT The Ca21-triggered merger of two apposed membranes is the deﬁning step of regulated exocytosis. CHOL is
required at critical levels in secretory vesicle membranes to enable efﬁcient, native membrane fusion: CHOL-sphingomyelin
enriched microdomains organize the site and regulate fusion efﬁciency, and CHOL directly supports the capacity for membrane
merger by virtue of its negative spontaneous curvature. Speciﬁc, structurally dissimilar lipids substitute for CHOL in supporting the
ability of vesicles to fuse: diacylglycerol, aT, and phosphatidylethanolamine support triggered fusion in CHOL-depleted vesicles,
and this correlates quantitatively with the amount of curvature each imparts to the membrane. Lipids of lesser negative curvature
than cholesterol do not support fusion. The fundamental mechanism of regulated bilayer merger requires not only a deﬁned
amount of membrane-negative curvature, but this curvature must be provided by molecules having a speciﬁc, critical
spontaneous curvature. Such a local lipid composition is energetically favorable, ensuring the necessary ‘‘spontaneous’’ lipid
rearrangements that must occur during native membrane fusion—Ca21-triggered fusion pore formation and expansion. Thus,
different fusion sites or vesicle types can use speciﬁc alternate lipidic components, or combinations thereof, to facilitate and
modulate the fusion pore.
INTRODUCTION
The involvement of speciﬁc membrane components in the
native membrane merger mechanism, including prefusion
protein functions (1,2) and lipidic functions during bilayer
coalescence (3,4), has been widely discussed. The contribu-
tion of lipidic membrane components speciﬁcally to the fu-
sion process is addressed by the stalk-pore hypothesis (3–16),
which deﬁnes the underlying energetics of bilayer merger via
a lipidic fusion pore. Different lipids affect the energy re-
quired to overcome the hydration layer, and affect bilayer
merger in terms that include membrane curvature. Lipids
with small hydrophilic headgroups relative to larger hydro-
phobic domains (e.g., ‘‘average molecular conformation’’)
are said to have negative spontaneous curvature and tend to
pack in concave structures at the lipid-water interface; lipids
of an opposite average molecular conformation are said to
have positive curvature and form convex, micelle-like struc-
tures. The spontaneous curvature of various lipids in hy-
drated assemblies has been measured (17–23). Investigations
into the role of lipids in the fusion process have shown that
the initial formation of high energy, transient, high curvature
lipidic intermediates (hemifusion) can be inhibited by addi-
tion of exogenous lipids of high positive curvature to the
interacting monolayers (24,25) or by removing endogenous
lipidic components of high negative curvature, such as
CHOL (25). In both cases, the net negative curvature is de-
creased, and the positive curvature increased. Thus, a local
concentration of negative curvature in the initially contacting
monolayers promotes hemifusion, the necessary ﬁrst transi-
tion to the fusion of two apposed bilayers; a focal enhance-
ment of positive curvature in the distal monolayers then
promotes transition to full fusion.
Liposome and viral fusion studies have highlighted the
contribution of molecules with negative spontaneous curva-
ture to the formation of the hemifusion intermediates pre-
dicted by the stalk-pore hypothesis, however, this has not
previously been demonstrated in a native system capable of
fast, Ca21-triggered membrane fusion. Isolated sea urchin
egg CV offer a robust, stage-speciﬁc, high purity preparation
for the study of native, Ca21-triggered membrane merger; by
all available criteria, CV-CV fusion proceeds through the
samemolecular pathway as exocytotic CV-PM fusion (26,27).
Most notably, these vesicles are amenable to rigorous bio-
chemical manipulation and molecular quantiﬁcation not pos-
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sible in intact cellular systems. Here we show that Ca21-
triggered fusion of CHOL-depleted CV can be selectively
rescued by the addition of structurally dissimilar lipids having
negative curvature comparable to CHOL.We highlight for the
ﬁrst time, to our knowledge, a direct, quantitative molar cor-
relation between the focal curvature contributions of speciﬁc,
structurally unrelated membrane components—CHOL, DOG,
DOPE, and aT—and the fundamental role of these speciﬁc
negative curvature components in the native mechanism of
Ca21-triggered membrane fusion (Table 1, Fig. 1).
MATERIALS AND METHODS
Materials
DiI, mßcd, hpßcd, aT, and hexadecane were from Sigma (St. Louis, MO).
CHOL-B was from Invitrogen (Carlsbad, CA). Cholesterol, DOPE, DOG,
DOPC, Me-DOPE, Me2-DOPE, DOPA, and all lipid standards for HPTLC
were from Avanti Polar Lipids (Alabaster, AL). All other chemicals were
minimally analytical grade.
Preparations, CV treatments, and fusion assays
CV were isolated from Strongylocentrotus purpuratus (Westwind Sea Labs,
Victoria, British Columbia, Canada) as previously described (26,28). All
experiments were carried out in BIM (210 mM potassium glutamate,
500 mM glycine, 10 mMNaCl, 10 mM PIPES, 50 mMCaCl2, 1 mMMgCl2,
1 mM EGTA, pH 6.7) supplemented with 2.5 mM ATP and protease in-
hibitors (25,28). Standard end-point and kinetic fusion assays were carried
out as previously described (25,26,29). CV were treated with 2 mM mßcd in
BIM for 30 min (25C). CHOL-loaded hpßcd was prepared as previously
described (25), and treatments were carried out as with mßcd. DOPC, DOPA,
DOPE, Me-DOPE, Me2-DOPE, aT, and DOG were delivered from 50 mM
(DOPC, DOPA, DOPE) or 200 mM (aT, DOG) stocks in hexadecane to a
ﬁnal solvent concentration of 0.1%. CHOL-B was delivered from a DMSO
stock to a ﬁnal solvent concentration of 0.75%, whereas C9NBD-T was
delivered from ethanol to a ﬁnal solvent concentration of 0.1%. Lipids in
organic solvents were either i), delivered directly to a suspension of CV
(optical density 1.0) and the suspension gently mixed by inversion, or ii),
diluted 10-fold into BIM and vortexed thoroughly before delivery to CV
suspensions (ﬁnal optical density 1.0); both delivery methods were of com-
parable efﬁcacy. In each experiment, parallel solvent controls were carried
out to determine the effects of organic solvent alone on CV-CV fusion. At the
concentrations used, none of the organic solvents had a signiﬁcant effect on
any of the parameters of fusion (P$ 0.5). Incubation of CV with exogenous
PLD (prepared as a concentrated stock in BIM) were carried out in BIM at
25C as with previous enzyme treatments (25,29). To ensure removal of any
unincorporated reagents, CV were centrifuged after all treatments and then
suspended in fresh BIM. CV were then counted using a hemacytometer (25).
Ca21-activity curves were ﬁt using the sigmoidal cumulative log-normal
model (25,30,31); control conditions were ﬁt with a two-parameter model
(plateau at 100%, by deﬁnition), whereas experimental conditions were ﬁt
with a three-parameter model (TableCurve 2D) to determine upper plateau
extent, Ca21 sensitivity (EC50), and sigmoidal curve-shape parameters.
Kinetic data were ﬁt with an established model (32). The spontaneous cur-
vature (1/R0p) for Me-DOPE and Me2-DOPE were estimated from a linear
extrapolation of 1/R0p versus degree of N-methylation for DOPC (three
methyl groups) and DOPE (zero methyl groups) (20,21,23).
Confocal microscopy
Eggs from S. purpuratus were isolated, washed, and dejellied as previously
described (26). A dilute suspension of eggs in artiﬁcial sea water (435 mM
NaCl, 40 mM MgCl, 15 mM MgSO4, 11 mM CaCl2, 10 mM KCl, 1 mM
EDTA, 10 mM HEPES, pH 8.0) was incubated with 20 mM DiI (delivered
from DMSO stock diluted into artiﬁcial sea water to a 1% ﬁnal concentration
of DMSO) for 20 min at 25C. Labeled eggs were washed three times with
sea water and stored suspended on ice until required. Cortices were isolated
on glass coverslips as previously described (31). Brieﬂy, DiI-labeled eggs
were allowed to settle onto poly-L-lysine treated (1.0 mg/ml) glass bottomed
culture dishes (MatTek, Ashland, MA) for 10 min, then eggs were sheared
with a stream of BIM delivered from an 18-gauge syringe; shearing was
forceful to produce regions of PM denuded of CV. Cortices were washed
with several volumes of BIM, and subsequently incubated with 15 mM
CHOL-B (delivered from DMSO diluted into BIM to a 1% ﬁnal concen-
tration) in BIM (20 min, room temperature). Images were acquired using
a Zeiss LSM-510 Meta confocal microscope (Carl Zeiss, Oberkochen,
Germany) using a 403 1.2 numerical aperture water immersion objective in
the inverted conﬁguration. Cortices were imaged using a series of Z plane
optical sections to produce an image stack. The CHOL-B signal was obtained
using laser excitation at 488 nm and imaged using a bandpass ﬁlter at 505–
530 nm; DiI was excited at 543 nm and imaged using a 560–615 nm
bandpass ﬁlter. Images were visualized and processed using ImageJ (33).
FIGURE 1 Chemical structures of speciﬁc negative curvature lipids, as in
Table 1. (A) DOPC. (B) DOPA. (C) Me2-DOPE. (D) Me-DOPE. (E) DOPE.
(F) DOG. (G) aT. (H) CHOL.
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Molecular analyses
CV membranes were isolated by ultracentrifugation (90 min, 200,000 3 g)
after lysis (34). Total cholesterol concentrations were measured using the
Amplex Red Cholesterol Assay kit (Molecular Probes, Eugene, OR) ac-
cording to manufacturer instructions. Fluorescent lipid analogs were deter-
mined by ﬂuorescence measurements on intact CV after removal of excess
reagent and washing with BIM in parallel with a dilution series of the ﬂuo-
rescent molecule (Wallac Victor II Microplate Reader, PerkinElmer, Boston,
MA). CV membrane lipids were extracted according to Bligh and Dyer (35)
with some modiﬁcations. Methanol and chloroform were added sequentially
to an intermediate ratio of 0.8:2:1 (H2O/CH3OH/CHCl3, v/v/v) and subse-
quently brought to a ﬁnal ratio of 1.8:2:2 with the sequential addition of
aqueous solution (0.1 M HCl, 1 M NaCl) and chloroform. The chloroform
phase was recovered, and the remaining aqueous phase was rinsed with an
additional 2 vol of chloroform. The organic phases were combined, dried
under vacuum, and stored under N2 (30C) before analysis. For DOPA,
DOPE, and DOG analysis, dried ﬁlms were resuspended in 2:1 chloroform/
methanol and loaded onto silica gel 60 HPTLC plates (EMD Chemicals,
Darmstadt, Germany) previously washed with chloroform/ethyl acetate (6:4)
and activated at 110C for 30 min. HPTLC was carried out essentially as
previously described (25). For aT analysis, dried ﬁlms were loaded as above
onto silica gel 60 preparative TLC plates (EMD Chemicals) and separated in
four sequential steps using the CAMAG AMD2 (CAMAG, Wilmington,
NC). Plates were developed to 30 mm with CH2Cl2/ethyl acetate/acetone
(80:16:4 v/v/v), then to 50, 70, and 90 mm with 92:8, 95:5, and 98:2 v/v
hexane/ethyl acetate, respectively. DOPA, DOPE, and DOGwere stained on
a plate with Nile Red (36) or were charred with CuSO4 (29) and the inte-
grated ﬂuorescence intensity was compared to a parallel dilution series of
lipid standards (25). Quantiﬁcation of aT was carried out on-plate using the
characteristic absorbance at 288 nm, with the CAMAG TLC2 scanner
(CAMAG). Integrated signal was compared to a parallel dilution series of
standards on the same TLC plate. Thus, all values reported in the text are the
result of direct quantiﬁcation of the amount of exogenous lipid incorporated
into CV membranes.
Statistical analyses
To deﬁne the minimal quantity of each lipidic species required to elicit full
recovery of fusion, a linear regression was ﬁt to the scatter data (see Fig. 3 C)
sequentially, increasing the number of data points from the origin until such a
time that increasing the number of points included signiﬁcantly altering the
slope and coefﬁcient of determination of the line. Data points below the break
point were deﬁned as the rising phase, and those above the break as the
plateau phase of the saturation curve. The X value at the point of intersection
between the linear ﬁt of the rising phase and the plateau was deﬁned as the
minimal quantity required for full recovery of fusion (see Fig. 3D). As it was
experimentally difﬁcult to incorporate either very small or very large
amounts of exogenous DOPE into the CV membrane, the minimal quantity
required for recovery of fusion was calculated as the average amount of
exogenous DOPE that elicited full fusion recovery in six experiments.
Two-sample two-tailed t-tests were used to determine differences (P ,
0.05, unless stated otherwise) of fusion parameters between experimental
conditions and parallel, internal controls. In all calculations, statistical error
was propagated using standard methods. All data are reported as mean6 SE.
RESULTS
We ﬁrst asked the question whether CHOL is generally en-
riched in areas of the membrane in which it would contribute
to the exocytotic fusion mechanism (e.g., areas of CV-PM
contact). CHOL-B, a probe selective for membrane regions
enriched in CHOL (37,38), was used to label cortex prepa-
rations made from oocytes in which the PM had been
prelabeled with the general membrane stain DiI (Fig. 2 A).
Confocal ﬂuorescence microscopy of these dual-labeled
cortices consistently revealed that, in the absence of vesicles,
only the PM is labeled and there is no correlation between the
DiI and the CHOL-B (Fig. 2, A and C, see region in upper left
of cortex versus CV-rich region in lower right of cortex).
However, PM regions containing CV show a consistent
correlation between DiI and CHOL-B; this correspondence
in labeling is neither homogeneous nor uniform but is clearly
localized to the region of the PM with docked CV (Fig. 2,
B–E). The apparent heterogeneity may be a reﬂection of the
labeling mechanism, although previous analyses do associate
CHOLwith the fusion machinery, which would be consistent
with its nonuniform distribution across the population of CV
FIGURE 2 Confocal analysis of the relative
CHOL distribution between the PM and CV of
S. purpuratus egg cortices. (A) DiI labeling was
carried out on intact oocytes before preparation of
cortices, to speciﬁcally label the plasma membrane.
(B) CV-PM cortex subsequent to labeling with
CHOL-B to indicate regions enriched in CHOL.
(C) Bright ﬁeld image of the cortex preparation
shown in A and B. (D) Overlay of A and B indicates
only partial correlation of DiI label in the PM with
the heterogeneous CHOL-B label. (E) Overlay of A,
B, and C indicates that CHOL-B labeling correlates
primarily with CV-rich regions; areas of the PM
denuded of CV have no detectable CHOL-B label.
(F) Line traces as indicated in E, reconstructed
from a Z stack of A and B, indicate that CHOL-B-
enriched regions are localized within and above
the plane of the PM, consistent with the position of
docked CV. Scale bar in A is 20 mm. Representative
of 10 cortices from four separate preparations.
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(25). Line scans suggest that the CHOL-enriched regions
labeled by CHOL-B are localized within and above the plane
of the PM (Fig. 2 F). Together, these results indicate that
the bulk of CHOL is associated with CV and/or the sites
of vesicle attachment to the PM. Additionally, upon Ca21-
triggering, the CHOL-B label underwent rapid dispersion into
the PM, consistent with exocytotic fusion and the subsequent
appearance of fusion ‘‘domes’’ (that verify vectorial discharge
of CV content across the PM (39)) as seen in the parallel bright
ﬁeld images (Supplementary Material, Movie S1).
To couple quantitative functional and molecular assays as
tightly as possible, as is required to effectively dissect mo-
lecular mechanisms, the role of CHOL and negative curva-
ture was further probed using isolated CV that retain the
minimal molecular machinery for intermembrane attach-
ment, Ca21 sensing, and fusion (25,26,28,29,40). Isolated,
free ﬂoating CV were treated with 2 mM mßcd to selectively
remove membrane CHOL (25,29). Relative to native, un-
treated CV, mßcd treatment resulted in a 31.4 6 5.9% re-
duction in CVmembrane CHOL. CHOL depletion correlated
with a 26.0 6 5.0% (n ¼ 5) reduction in fusion extent (Fig.
3 E) and a rightward shift in Ca21 sensitivity of 65.96 15.0
mM [Ca21]free (n ¼ 5; Fig. 3 A), consistent with previous
observations (25,29). Similar inhibitory effects were also
observed for fusion kinetics (Fig. 3 B). Delivery of exoge-
nous CHOL with hpßcd restored membrane CHOL to that of
untreated CV, and the extent, Ca21 sensitivity, and kinetics
of fusion were recovered to that of control (Fig. 3, A, B, and
D). In contrast, incorporation of the negative curvature ana-
logs DOG, DOPE, or aT to CHOL-depleted CV selectively
recovered the ability to fuse, but not the Ca21 sensitivity or
kinetics of fusion (Fig. 3, A and B). Similar to CHOL (25),
supplementation of exogenous DOG, aT, and DOPE into
native CV did not affect any fusion parameters (data not
shown). As a structural analog of CHOL, CHOL-B was also
delivered to the CV membrane after CHOL depletion. Al-
though the spontaneous curvature of cholesteryl esters has
not been determined experimentally, esteriﬁcation of the 39
hydroxyl group is structurally consistent with substantially
decreased negative curvature (e.g., more characteristic of a
neutral or even positive curvature molecule), particularly
when the conjugate includes a heterocyclic ﬂuorophore.
Neither CHOL-esters (data not shown) nor CHOL-B (Fig.
3 A) were able to rescue any parameters of fusion, despite
quite effective incorporation into the CV membrane (veriﬁed
by ﬂuorometry).
In a single nativeCV, an average of 54.56 5.2 amol CHOL
provide 2.20 6 0.30 units of speciﬁc curvature (deﬁned
herein as the amol lipid per CV 3 spontaneous curvature,
1/R0p, A˚
1). After CHOL depletion using a standardized
treatment with 2 mM mßcd (25,29), the speciﬁc curvature
contributed by CHOL was1.516 0.29 amol  A˚1 per CV,
leaving a negative curvature deﬁcit of 0.696 0.24 amol  A˚1.
Rescue of fusion by enrichment of CHOL-depleted vesicles
with DOPE and DOG correlated quantitatively with the re-
spective negative curvature contributions of these lipids rather
than the actual molar incorporation (Table 1; Fig. 3,D and E),
and was equivalent to the speciﬁc curvature introduced
by CHOL itself for the full rescue of fusion, 0.79 6 0.15
amol  A˚1 (P . 0.5). With DOG having the highest mea-
sured negative curvature (23), .2-fold higher than CHOL,
proportionally less DOG as CHOL was required to effec-
tively recover the extent of fusion (Fig. 3, C–E). A strong
linear correlation exists between the minimal quantity of each
of CHOL,DOPE, andDOG required to fully rescue the fusion
extent and the respective measured spontaneous curvature of
these molecules (Fig. 3 D, R2 ¼ 0.90). Relative to CHOL,
DOG, andDOPE, the required curvature contributed byaT to
fully recover the fusion extent is;2-fold less (Fig. 3D). This
is consistent with observations that aT has effectively no
transbilayer mobility over the timescale of several hours (41);
thuswhereas CHOL,DOG, andDOPE can rapidly equilibrate
between the inner and outer leaﬂets of the vesicle membrane
(37,42–44), aT remains almost exclusively in the outer leaf-
let. Since CHOL, DOG, and DOPE will effectively reach an
equilibrium distribution within the time course of a single
experiment (;1 h), the resulting curvature contribution in
the outer monolayer will be approximately half of the total
curvature contribution (;0.40 6 0.08 amol  A˚1 for
CHOL). Taking transbilayer equilibration into account, there
exists a strong linear correlation (coefﬁcient of determination
R2 ¼ 0.92) between the spontaneous negative curvature of
CHOL, DOPE, aT, DOG (Table 1), and the minimal quantity
of each molecule incorporated into the outer monolayer of the
vesicle to effect full recovery of the ability to fuse (e.g., extent,
Fig. 3, C and D). Additionally, rescue of fusion with CHOL,
aT, and DOG was dose-dependent, and resulted in a graded
recovery of fusion extent (Fig. 3C), conﬁrming a relationship
between the negative curvature contribution and the extent
of fusion. As indicated (Table 1), the spontaneous curvature
measurements of DOPEwere available in both water (18–22)
and high salt buffer (150 mM KCl, pH 7) (20), whereas
the remaining lipids (DOG, aT, and CHOL) were each
measured in water only (17,18,21,23). As DOPE is the only
selected lipid of zwitterionic character (with DOG, aT, and
CHOLbeing neutral) it is likely the only lipid thatwould show
signiﬁcant variation in the presence of aqueous ions. The
measurements made in high salt buffer more appropriately
approximate the aqueous environment surrounding the CV in
these experiments, and as such we have used these measure-
ments in all subsequent calculations; however, if we assume
the curvature to be that measured in water (0.035 6 0.001
A˚1), the speciﬁc curvature contribution afterDOPE recovery
was still 0.51 6 0.06 amol  A˚1.
Treatment of CV with 25.3 mM of the CHOL binding
polyene antibiotic ﬁlipin, to sequester CHOL in the mem-
brane rather than remove it (25), resulted in a selective 30.46
1.8% inhibition of the extent (n ¼ 4, P, 13 105), but not
Ca21 sensitivity of fusion (Fig. 4, A–C). This inhibition was
fully reversed after delivery of 1.22 6 0.23 amol/CV of aT.
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Subsequent quantitative analysis showed that the graded re-
covery of fusion extent correlated linearly with the amount of
aT delivered to the membrane in a manner consistent with the
previous results (Figs. 3 C and 4 C). The total amount of aT
required to fully recover the extent of fusion was ;3.6-fold
less than was required to rescue inhibition after a comparable
mßcd treatment (Fig. 3). To examine the speciﬁcity of the
recovery, an identical experiment was carried out using
C9NBD-T; this molecule is structurally related to aT but
with a ﬂuorophore incorporated such that the structural
conformation is consistent with a substantially reduced
negative curvature. C9NBD-T was unable to recover the
FIGURE 3 Treatment of CHOL-depleted CV with negative curvature analogs rescues the extent but not the Ca21 sensitivity or kinetics of CV-CV fusion.
(A) Ca21 activity curve of CV treated with 2 mM mßcd or sequentially with mßcd and 100 mM DOPE, 2 mM CHOL-loaded hpßcd, or 200 mM DOG or aT
(n ¼ 3–7). (B) Kinetics of CV-CV fusion in response to 157 6 17 mM ½Ca21free (n ¼ 3); labels as in A. (C) Relationship between total exogenous lipid
incorporated into CV membranes, as determined by quantitative analysis of isolated CV membranes, and the extent of fusion after standard mßcd treatment
(red triangle). Labels as in A, except open diamond (Me-DOPE), open square (Me2-DOPE), and open circle (DOPC). (D) The amount of a given reagent
incorporated into CV membranes required to fully recover fusion extent correlates linearly with the amount of negative curvature each species contributes.
Labels as in A except crosses, which indicate half the minimal quantities of CHOL, DOPE, and DOG required for fusion recovery, to represent the quantity
localized to the vesicle outer leaﬂet (blue ﬁt y¼ 99.2x1 12.2, R2 ¼ 0.92, red ﬁt y¼ 195x1 25.5, R2 ¼ 0.90). (E) Summary of CV fusion recovery after mßcd
treatment and subsequent delivery of CHOL or curvature analogs in the quantities shown in D; DOPE, aT, and DOG fully support the ability to fuse, whereas
DOPC, Me-DOPE, and Me2-DOPE do not, and DOPA further inhibits the extent of fusion. *(P, 0.01), **(P, 0.001) indicates difference from control and
other conditions (n ¼ 3–7).
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extent of fusion, despite extensive incorporation (13.4 6 0.5
amol/CV) in the membrane, as conﬁrmed by washing away
of excess reagent followed by ﬂuorometric assessment (Fig.
4 A, inset).
Previous studies have detailed the potent inhibitory effects
on fusion of adding high positive curvature molecules, such
as LPC, to secretory vesicles (24,45), including addition of
LPC to CHOL-depleted CV (25). At molar quantities com-
parable to CHOL, delivery of DOPC (20.8 6 7.1 amol/CV),
a lipid with effectively neutral curvature (23), to CHOL-
depleted vesicles, had no effect on any of the fusion param-
eters (n¼ 4, Fig. 3 C). Similarly, additions of 24.56 3.6 and
22.3 6 4.0 amol/CV of Me-DOPE and Me2-DOPE, respec-
tively, two derivatives of DOPE with spontaneous curvature
predicted to be intermediate to DOPE and DOPC (46), also
failed to recover the extent of fusion (n ¼ 4, Fig. 3 C). Based
on an estimated spontaneous curvature of –0.0313 A˚1, Me-
DOPE incorporation amounts to 0.767 6 0.113 amol 
A˚1, equivalent to the curvature deﬁcit after CHOL depletion
(Fig. 3). This suggests that total negative curvature alone is
insufﬁcient to enable fusion, but rather that only molecules of
a speciﬁc negative spontaneous curvature can support the
molecular rearrangements leading to pore formation.
Similarly, and in contrast to the effects of DOG, DOPE,
and aT, addition of another negative curvature analog,
DOPA, was also unable to recover the ability of CHOL-
depleted CV to undergo Ca21-triggered fusion (Fig. 5 A).
Treatment of native CV with DOPA also resulted in a potent
inhibition of the extent and Ca21 sensitivity of fusion, with a
corresponding decrease in kinetics (Fig. 5 A). The measured
spontaneous curvature of DOPA is 0.022 A˚1 (20). Thus
delivery of 6.4 6 0.9 amol of DOPA per CV correlates to
a speciﬁc curvature contribution of –0.145 6 0.020 amol 
A˚ 1, which, although less net curvature than required for
complete recovery of fusion extent after CHOL depletion, is
comparable to the amounts of CHOL, aT, and DOG deliv-
ered to CV to effect partial recovery (Fig. 3 C). As with
DOPE, the spontaneous curvature of DOPA becomes more
negative in the presence of aqueous salts (Table 1). The
TABLE 1 Measured spontaneous curvatures of speciﬁc lipids
Membrane
component
Spontaneous
curvature
(1/R0p, A˚
1) Reference
DOPC 0.0061 6 0.0011 (23)
DOPA 0.022* (20)
0.0077y
Me2-DOPE 0.0187z
Me-DOPE 0.0313z
DOPE 0.044 6 0.001* (20)
0.0348 6 0.0009y (18-22)
CHOL 0.0404 6 0.0036 (18)
aT 0.073 (17)
DOG 0.093 6 0.006 (21,23)
*Measured in 150 mM KCl, pH 7.
yMeasured in water.
zExtrapolated (46).
FIGURE 4 Inhibition of CV-CV fusion extent by ﬁlipin treatment was reversed by the addition of molecules of high negative curvature. (A) Ca21 activity
curve of CV treated with 25.3 mM ﬁlipin, or sequentially with ﬁlipin and 50, 100, or 200 mM aT or C9NBD-T (n ¼ 4). Fluorescence measurements (inset)
determined incorporation of 13.46 0.5 amol/CV of C9NBD-T. (B) Kinetics of CV-CV fusion in response to 1446 16mM ½Ca21free (n¼ 4). C. Delivery of aT to
ﬁlipin-treated CV restores fusion capacity in a dose-dependent manner, correlating with the amount of aT incorporated into the membrane (P , 0.01, n ¼ 4).
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spontaneous curvature of DOPA in water is 0.0077 A˚1
(20), similar to that of DOPC. Additionally, enzymatic gen-
eration of endogenous PA in CV membranes via PLD ac-
tivity showed comparable inhibitory effects on fusion extent
(Fig. 5 B); however, effects on Ca21 sensitivity and kinetics
were less substantial than with exogenous DOPA (Fig. 5 B,
inset). Quantitative analysis of PLD-treated CV membranes
indicated that endogenously generated PA was required at
levels substantially less than the exogenous DOPA to yield
comparable inhibitory effects. This likely reﬂects the local-
ized production of a particular range of PA species, as op-
posed to exogenous supplementation with only DOPA.
DISCUSSION
The ability of vesicles to undergo Ca21-triggered fusion is
dependent on the localized presence of CHOL as a molecule
of high negative spontaneous curvature that supports the
formation and transition of transient fusion intermediates
(25,47,48). Imaging conﬁrms that CHOL is predominantly
localized to CV-enriched regions of the PM. The funda-
mental ability of CHOL-depleted CV to fuse, as assessed by
the total extent of fusion, is rescued by the quantitative re-
covery of membrane negative curvature using speciﬁc,
structurally dissimilar lipidic curvature analogs, each with a
spontaneous negative curvature (1/R0p) equivalent to or more
negative than CHOL.
Speciﬁc effects of negative curvature lipids
All Ca21-activity curves, including the fusion of CHOL-
depleted and lipid-recovered samples, were translationally
invariant. Thus, despite the different treatments used, such
conservation of the underlying curve-shape parameters of
each of these Ca21-activity curves is minimally consistent
with a single common fusion mechanism (25,26,29,31).
Nonetheless, rescue of fusion capacity with DOPE, aT, and
DOG does not correlate with rescue of Ca21 sensitivity or
kinetics of fusion, indicating that these parameters can be
effectively separated experimentally (25,29). Although the
ability of vesicles to undergo fusion is dependent in part on
the focal curvature of the membrane, the efﬁciency (Ca21
sensitivity and kinetics) of fusion is deﬁned by membrane
components associated with critical CHOL levels, most
probably via organization of proteins and lipids within
CHOL and sphingomyelin-enriched microdomains (25,29).
The activity or interactions of various protein components of
the fusion machinery may be differentially modulated by
CHOL levels in CV, either through direct interaction with
CHOL or through general changes in the lipid environment.
Such effects of CHOL on the activities of different membrane
proteins are quite well documented (49–53). Thus it is not
inconceivable that the localization or sensitivity of Ca21-
sensing molecules may be differently affected by local al-
terations in CHOL density relative to the effects of these
alterations on the protein machinery that promotes rapid
fusion kinetics.
Lipidic curvature analogs, although likely able to associate
with CHOL-rich microdomains, do not actively contribute to
the formation or stability of such microdomains (54,55). As
DOPE-, aT-, and DOG-recovered CV are able to undergo the
native Ca21-triggered fusion reaction without stabilizing
microdomains or reorganizing efﬁciency factors at the fusion
site, these results are consistent with the concept of a con-
served minimal fusion machine of lower inherent Ca21
sensitivity, with the associated protein and lipid components
modulating the efﬁciency of triggering, pore formation, and
pore expansion (25,28,29,40). This selective ability of spe-
FIGURE 5 Phosphatidic acid inhibits fusion. Treatment of CHOL-
depleted CV with the curvature analog DOPA did not recover but rather
further inhibited the extent of CV-CV fusion (purple). Similarly, supple-
menting native CV with DOPA (green) inhibited fusion to approximately
the same extent as did depletion of CHOL. (A) Ca21 activity curve of CV
treated with 200 mM DOPA, 2 mM mßcd or sequentially with mßcd and
DOPA (n ¼ 4). (Inset) Kinetics of CV-CV fusion in response to 236 6 34
mM ½Ca21free (n ¼ 4). In a comparable fashion, the generation of endog-
enous PA in native CV also inhibits the extent, Ca21 sensitivity, and kinetics
of CV-CV fusion. (B) Ca21 activity curve of CV treated with increasing
concentrations of exogenous PLD as indicated. (Inset) Kinetics of CV-CV
fusion in response to 91 6 15 mM ½Ca21free (n ¼ 5).
3982 Churchward et al.
Biophysical Journal 94(10) 3976–3986
ciﬁc negative curvature molecules to recover the inherent
ability to fuse demonstrates that negative curvature itself is
one necessary component of the fast native Ca21-triggered
fusion mechanism. This quantitative ﬁnding appears most
consistent with the stalk-pore model as a mechanism for
native membrane fusion, with negative curvature compo-
nents contributing to initial membrane dimpling or formation
of point-like protrusion (7) and the formation and expansion
of the hemifusion diaphragm (3,5,6,56–58).
Negative curvature acts only in the
contacting monolayers
The formation of a stalk intermediate occurs exclusively
between the outer monolayer of a single CV and the cyto-
plasmic leaﬂet of the PM (in CV-PM fusion) or between the
outer monolayers of two adjacent CV (in homotypic CV-CV
fusion). As aT has effectively no transbilayer mobility (41)
within the timescale of a single experiment (;1 h), the
ﬁnding that the curvature contributed by aT to fully recover
fusion is approximately half that required of CHOL, DOG, or
DOPE demonstrates that the negative curvature contribution
is via the outer monolayer of the CV, again consistent with
the stalk-pore hypothesis. Thus negative curvature is required
speciﬁcally for the formation of a stalk intermediate between
the contacting monolayers of two adjacent CV. This is con-
sistent with observations that high positive curvature mole-
cules such as LPC reversibly arrest fusion at a stage that
follows Ca21 triggering but before monolayer merger
(24,45). After sequestration of CHOL by ﬁlipin treatment,
aT is required at doses even lower than those for recovery of
fusion after CHOL depletion with mßcd. Clearly, whereas
both mßcd and ﬁlipin functionally ‘‘remove’’ CHOL from
the membrane, the ﬁlipin treatment requires less curvature
contribution for recovery, since this has only to effect rescue
of the ability to fuse; this is consistent with suboptimal doses
of CHOL effecting only partial rescue of the ability to fuse,
with the full native complement of CHOL required to com-
pletely rescue both fusion and efﬁciency (25). In effect, this is
most likely due to differences in the modes of action of mßcd
and ﬁlipin, in particular the fact that only mßcd is highly
disruptive to CHOL enriched microdomains (25,59).
PA is unlikely to act directly in the fusion step
of exocytosis
The role of PA in fusion via PLD activity has been discussed
both indirectly in vesicle trafﬁcking and exocytosis (60) and
directly in the aggregation and fusion of liposomes (61). As
the incorporation of exogenous DOPA into CV membranes,
or the formation of endogenous PA did not enhance the Ca21
sensitivity, and potently inhibited fusion kinetics (Fig. 5), it
appears unlikely that intermembrane Ca21 binding to PA
headgroups plays any signiﬁcant role in the native fusion
mechanism. Indeed our results suggest that the positive role
PA may play in the native exocytotic pathway is not through
a direct role in Ca21 triggered membrane merger, but likely
upstream in vesicle attachment and kinase-related modula-
tory functions (62); in terms of fusion, PA may thus actually
function as a local negative regulator. It is not clear if the
transbilayer distribution of PA might have differential ef-
fects; given the relatively slow transbilayer mobility of PA
the treatments used in this study (e.g., exogenous PLD or
DOPA) are likely only to affect PA levels in the outer leaﬂet
of the CV membrane. Previous studies implicating PA in the
fusion process have typically involved manipulations of en-
dogenous PLD, and as such may have a more symmetric
effect on the distribution of PA (63,64). As with Me-DOPE,
Me2-DOPE, and DOPC, the spontaneous negative curvature
of DOPA is substantially less than that of CHOL, consistent
with the ﬁnding that lipids with spontaneous curvature
equivalent to or more negative than CHOL are able to sub-
stitute for CHOL in the fusion process, whereas lipids of
lesser negative curvature cannot. PA may also associate with
different regions of the CV membrane due to its inherent
charge, whereas CHOL, DOPE, aT, and DOG are able to
spatially and/or functionally associate with the docking and
calcium-sensing machinery. The observation that exogenous
PLD potently inhibits fusion extent at lower membrane
concentrations of PA, relative to the delivery of exogenous
DOPA, implies that endogenous PA may be generated at
speciﬁc sites, or from speciﬁc molecular species that asso-
ciate with different regions of the CV membrane than does
DOPA. Additionally, as PLD treatments less potently inhibit
the Ca21 sensitivity and kinetics of fusion, relative to exog-
enous DOPA, PA may directly and potently inhibit the for-
mation of high curvature fusion intermediates, whereas the
inhibitory effects on efﬁciency may be related to less speciﬁc
charge effects. As an anionic lipid, PA can create defects in
lipid packing due to lateral phase separation driven by the
binding of divalent ions; this would also result in the ag-
gregation of proteins with a high afﬁnity for PA (65).
Membrane lipids deﬁne the initial stalk formation
Of the lipids examined in this study, three have measured
spontaneous curvature that is equivalent to or more negative
than CHOL (DOPE, aT, and DOG) whereas six have mea-
sured or predicted spontaneous curvature that is less negative
than CHOL (DOPC, Me-DOPE, Me2-DOPE, DOPA,
CHOL-B, and C9NBD-T). The functional response of
CHOL-depleted CV to the delivery of each of these lipid
species parallels this division: whereas a lesser quantity of a
lipid having greater spontaneous negative curvature than
CHOL (aT or DOG), or a similar amount of an equivalent
curvature molecule (DOPE), both rescue fusion (Fig. 3), a
lipid of less spontaneous negative curvature is unable to
substitute for CHOL in the fusion process despite providing
the same net negative curvature contribution (Figs. 3 C and
5). This implies not only that a total deﬁned quantity of
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membrane negative curvature is required to enable fusion,
but also that the components that contribute the curvature
must have a speciﬁc, critical spontaneous curvature value to
effectively support fusion pore formation.
Extending these observations, including the enrichment of
CHOL in CV and at docking/fusion sites on the PM (Fig. 2),
we can predict that the curvature provided by CHOL is re-
quired to support the energetically favorable formation of a
high curvature stalk intermediate. As the monolayer spon-
taneous curvature is the weighted average of the spontaneous
curvature of all of the membrane components forming the
stalk, the local lipid composition will deﬁne the speciﬁc size
of the initial stalk. If, in addition to CHOL, the local mem-
brane is also enriched in other negative curvature molecules
such as aT or DOG, the total curvature of the stalk inter-
mediate would be less still, and thus more favorable for rapid
pore formation (12,13).
Cholesterol at the site of fusion
The data presented here quantitatively extend our under-
standing of the fusion process. Our previous studies indicate
that the fusion site is organized by microdomains enriched in
CHOL and sphingomyelin (25,29), enabling spatial coordi-
nation of protein and lipid components essential to membrane
deformation/bending, Ca21-sensing, triggering, and modu-
lation. In light of these ﬁndings, we hypothesize that the li-
pidic fusion site (the site of initial formation of point-like
protrusion (7) and subsequent stalk formation) is enriched in
CHOL and other speciﬁc negative curvature components
(e.g., phosphatidylethanolamine, diaglycerol, aT). We fur-
ther suggest that this lipidic fusion site may exist in one of
three possible states. First, the fusion site may exist in a
liquid-disordered state capable of rapidly forming high cur-
vature structures (66) as a region of varied ﬂuidity within
a single intact microdomain. Second, the fusion site may
be organized as a discrete (liquid-disordered) lipid phase
bounded by multiple liquid-ordered microdomains (67).
Finally, the fusion site may exist as a CHOL-rich, liquid-
ordered domain in resting CV, which rapidly transitions to a
liquid-disordered phase as a result of the physiological trig-
gering event, likely mediated by protein conformational
changes upon Ca21-activation (67). The challenge is now to
experimentally test these possibilities.
Although the necessary negative curvature is largely con-
tributed by CHOL in CV membranes, these ﬁndings imply
that different fusion sites, vesicles, or secretory cell types
could use other lipidic components, in addition to CHOL or
similar endogenous sterols, to provide optimal local negative
curvature to initiate and modulate the fusion process. CHOL
is also known to promote the membrane active effects of such
negative curvature lipids (47). An optimized lipid composi-
tion may serve to further reduce energy constraints arising
from the molecular reorganization required for stalk forma-
tion and subsequent pore opening and expansion (1,68,69).
As an essential component of the native fusion mechanism,
effects on membrane negative curvature must be assessed in
any manipulations used to probe the native fusion mecha-
nism (70).
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